Literature DB >> 16007501

Dengue virus M protein C-terminal peptide (DVM-C) forms ion channels.

A Premkumar1, C R Horan, P W Gage.   

Abstract

A chemically synthesized peptide consisting of the C-terminus of the M protein of the Dengue virus type 1 strain Singapore S275/90 (DVM-C) produced ion channel activity in artificial lipid bilayers. The channels had a variable conductance and were more permeable to sodium and potassium ions than to chloride ions and more permeable to chloride ions than to calcium ions. Hexamethylene amiloride (100 microM) and amantadine (10 microM), blocked channels formed by DVM-C. Ion channels may play an important role in the life cycle of many viruses and drugs that block these channels may prove to be useful antiviral agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007501     DOI: 10.1007/s00232-005-0744-9

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  14 in total

1.  The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers.

Authors:  K C Duff; R H Ashley
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

2.  Amantadine blocks channel activity of the transmembrane segment of the NB protein from influenza B.

Authors:  W B Fischer; M Pitkeathly; M S Sansom
Journal:  Eur Biophys J       Date:  2001-10       Impact factor: 1.733

3.  Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu.

Authors:  Gary D Ewart; Kerry Mills; Graeme B Cox; Peter W Gage
Journal:  Eur Biophys J       Date:  2002-03       Impact factor: 1.733

4.  Dengue virus premembrane and membrane proteins elicit a protective immune response.

Authors:  M Bray; C J Lai
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

5.  Influenza virus M2 protein has ion channel activity.

Authors:  L H Pinto; L J Holsinger; R A Lamb
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

6.  Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride.

Authors:  A Premkumar; L Wilson; G D Ewart; P W Gage
Journal:  FEBS Lett       Date:  2004-01-16       Impact factor: 4.124

7.  The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine.

Authors:  Stephen D C Griffin; Lucy P Beales; Dean S Clarke; Oliver Worsfold; Stephen D Evans; Joachim Jaeger; Mark P G Harris; David J Rowlands
Journal:  FEBS Lett       Date:  2003-01-30       Impact factor: 4.124

8.  Reconstitution of the influenza virus M2 ion channel in lipid bilayers.

Authors:  M T Tosteson; L H Pinto; L J Holsinger; R A Lamb
Journal:  J Membr Biol       Date:  1994-10       Impact factor: 1.843

Review 9.  Modification of membrane permeability by animal viruses.

Authors:  L Carrasco
Journal:  Adv Virus Res       Date:  1995       Impact factor: 9.937

10.  Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.

Authors:  R J Sugrue; A J Hay
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  16 in total

1.  Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins.

Authors:  Filomena A Carvalho; Fabiana A Carneiro; Ivo C Martins; Iranaia Assunção-Miranda; André F Faustino; Renata M Pereira; Patricia T Bozza; Miguel A R B Castanho; Ronaldo Mohana-Borges; Andrea T Da Poian; Nuno C Santos
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

2.  Heterocyclic Inhibitors of Viroporins in the Design of Antiviral Compounds.

Authors:  Vadim A Shiryaev; Yuri N Klimochkin
Journal:  Chem Heterocycl Compd (N Y)       Date:  2020-07-17       Impact factor: 1.277

3.  Junctin and triadin each activate skeletal ryanodine receptors but junctin alone mediates functional interactions with calsequestrin.

Authors:  Lan Wei; Esther M Gallant; Angela F Dulhunty; Nicole A Beard
Journal:  Int J Biochem Cell Biol       Date:  2009-05-04       Impact factor: 5.085

4.  Amiloride derivatives inhibit coxsackievirus B3 RNA replication.

Authors:  David N Harrison; Elena V Gazina; Damian F Purcell; David A Anderson; Steven Petrou
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

5.  Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds.

Authors:  Laura I Levi; Nina F Gnädig; Stéphanie Beaucourt; Malia J McPherson; Bruno Baron; Jamie J Arnold; Marco Vignuzzi
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

6.  Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity.

Authors:  H-Heinrich Hoffmann; Peter Palese; Megan L Shaw
Journal:  Antiviral Res       Date:  2008-06-13       Impact factor: 5.970

7.  Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection.

Authors:  Mudassar Ali; Rajan Kumar Pandey; Nazia Khatoon; Aruna Narula; Amit Mishra; Vijay Kumar Prajapati
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

8.  Potential Viroporin Candidates From Pathogenic Viruses Using Bacteria-Based Bioassays.

Authors:  Prabhat Pratap Singh Tomar; Rivka Oren; Miriam Krugliak; Isaiah T Arkin
Journal:  Viruses       Date:  2019-07-09       Impact factor: 5.048

9.  A 2a/1b full-length p7 inter-genotypic chimeric genome of hepatitis C virus is infectious in vitro.

Authors:  G Haqshenas; X Dong; G Ewart; S Bowden; E J Gowans
Journal:  Virology       Date:  2006-11-09       Impact factor: 3.616

10.  Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.

Authors:  Andrew C Sayce; Dominic S Alonzi; Sarah S Killingbeck; Beatrice E Tyrrell; Michelle L Hill; Alessandro T Caputo; Ren Iwaki; Kyoko Kinami; Daisuke Ide; J L Kiappes; P Robert Beatty; Atsushi Kato; Eva Harris; Raymond A Dwek; Joanna L Miller; Nicole Zitzmann
Journal:  PLoS Negl Trop Dis       Date:  2016-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.